Study shows who survives Burkitt lymphoma EurekAlert (press release) The same regimen of intensive chemotherapy and the monoclonal antibody rituximab are recommended for most patients. "There was little available for Burkitt lymphoma in terms of prognostic factors, indicators or scoring," said Dr. Jorge Castillo, an ... |
